Advaxis, Incorporated


Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board. Advaxis is developing attenuated live Lm vaccines that deliver engineered tumor antigens, which stimulate multiple simultaneous immunological mechanisms to fight cancer.

Wednesday, January 13, 2010

Advaxis US Patent information.

Advaxis owns 23 issued patents issued within its licenses portfolio and 22 pending patent applications. There are an additional 27 pending patent applications that the Company is currently negotiating the rights to with the University of Pennsylvania, the owner of these patents. There is no assurance that the parties will enter into this agreement, and that the Company will gain the rights to these additional 27 patents.
Posted by at